Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 13, 2003

View Archived Issues

Omiloxetine characterized as SSRI with potential in depression

Improvement associated with AC-2592 in advanced heart failure patients

Beneficial effects of NM-702 in intermittent claudication

Similar efficacy of CVT-3146 and adenosine in detecting myocardial ischemia

Two series of complement C5a receptor modulators patented by Neurogen

Merck claims novel cannabinoid CB1 modulators with utility as antiobesity agents

New pyridoxal-based HIV integrase inhibitors covered by Pharmacor patent

AstraZeneca researchers design novel GSK-3 inhibitors for AD therapy

Japanese team identifies compounds with leukocyte-enhancing and DPP-IV-inhibitory activity

Novel HIV protease inhibitors prepared and tested at Pharmacor

Lilly scientists discover new ERbeta agonists for use in prostate cancer

Rho kinase inhibitors discovered at Sumitomo

Assessment of the benefits of enfuvirtide in HIV-infected patients

Good efficacy and safety profile of ocinaplon in GAD

Efficacy and safety of NO-aspirin demonstrated in mice and in healthy subjects

Positive preliminary results for AVR-118 in cachexia

Exenatide meets glucose control endpoint in second of three pivotal trials

Arpida and Polyphor to discover new antibacterial and antifungal compounds

Six-month Eligard product completes phase III trial

Enrollment begins in ASSENT 4 PCI trial

EpiTan plans IND filing for Melanotan

Immunomedics negotiating return of epratuzumab rights from Amgen

Treatment under way in ML's phase II prostate cancer study

No morning residual effects after middle-of-night administration of indiplon

Plexxikon supplies novel kinase inhibitor to Genentech

Completion of first dose level in Oxycyte phase I study

Grant supports development of Resmycin

Cognition-enhancing effects demonstrated for selective histamine H3 receptor antagonist

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...